Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Colorectal Cancer × Panitumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 93 Colonic Neoplasms 25 Rectal Neoplasms 24 Neoplasm Metastasis 24 Neoplasms 21 Carcinoma, Non-Small-Cell Lung 11 Head and Neck Neoplasms 9 Esophageal Neoplasms 9 Pancreatic Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 6 Colorectal Cancer Metastatic 6 Cholangiocarcinoma 6 Carcinoma, Squamous Cell 6 Lung Neoplasms 5 Carcinoma 5 Ovarian Neoplasms 4 Breast Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Adenocarcinoma Of Esophagus 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Solid Tumors 2 Inflammatory Breast Neoplasms 2 Glioma 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Oxaliplatin 4 Cetuximab 4 regorafenib 3 Irinotecan 3 trifluridine tipiracil drug combination 2 surufatinib 2 Fluorouracil 2 Drug Therapy 2 Capecitabine 2 Bevacizumab 2 raltitrexed 1 plocabulin 1 paclitaxel poliglumex 1 nimotuzumab 1 irinotecan sucrosofate 1 durvalumab 1 defactinib 1 aflibercept 1 Panitumumab 1 N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide 1 HMPL-013 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03311750 2021-06-07

A-REPEAT

Hellenic Cooperative Oncology Group

Phase 2 Terminated

Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡